EXPLORE CONNECTIONS
XPA tumor variants lead to defects in NER that sensitize cells to cisplatin
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.